Allergen-specific immune response induction

The term "Allergen-specific immune response induction" refers to the complex biological process by which the immune system recognizes and responds specifically to environmental allergens. This is not a single molecular target or receptor but rather an orchestrated series of events involving antigen-presenting cells, T lymphocytes (especially CD4+ subsets), B lymphocytes producing specific antibodies (IgE and later IgG subclasses), mast cells, basophils, eosinophils, and various cytokines. The balance between different types of T helper cells—particularly Th2 cells promoting allergy versus regulatory Tr1/FOXP3+ Treg cells promoting tolerance—determines whether an individual develops allergic disease or remains tolerant to environmental antigens[1][3]. In clinical practice, allergen immunotherapy aims to induce a tolerant state by modulating these responses through repeated controlled exposure to allergens. This leads to increased regulatory mechanisms such as IL‑10–secreting Tr1/Treg cell activity; suppression of effector Th2 responses; reduced production of pathogenic IgE; increased production of blocking antibodies like IgG4; and decreased activation/recruitment of mast cells, basophils, and eosinophils[2][3][4]. Because "Allergen-specific immune response induction" describes a physiological/pathological process rather than a discrete molecular entity or druggable target such as a receptor or enzyme—and because it encompasses multiple cellular pathways—it should not be classified as a therapeutic target per se. If you are seeking information on specific molecules involved in this pathway for targeting purposes—such as FcεRI (high-affinity IgE receptor), CD23 (low-affinity IgE receptor), IL‑4Rα subunit—or key cytokines like IL‑10 or FOXP3+ regulatory proteins—those would be more appropriate canonical targets for structured data extraction. In summary: "Allergen-specific immune response induction" is not itself a molecular target but describes an integrated immunological phenomenon central to allergy pathogenesis and therapy.[1][2][3]

Other names

Allergen-specific immune responseInduction of allergen-specific immunityAllergen sensitization processAllergic sensitization

Desensitization via repeated exposure to specific allergens (immunotherapy)[2][4]; Modulation of T and B cell responses[2][3][4]; Induction of regulatory T cells and shift from Th2 to Tr1/Th1 phenotype[3][4]